名稱 | bTMB-P1 (22.91) Reference Standard |
型號(hào) | CBP80001-10 |
報(bào)價(jià) | ![]() |
特點(diǎn) | bTMB-P1 (22.91) Reference Standard |
產(chǎn)品搜索
相關(guān)文章
- 免疫療法對(duì)一類常見(jiàn)白血病顯療效
- 羅氏乳腺癌新藥獲英國(guó)NICE批準(zhǔn)用于HER2乳腺癌新輔助治療
- 腫瘤細(xì)胞內(nèi)的膠原蛋白有哪些作用?
- FH標(biāo)準(zhǔn)品上新
- STR標(biāo)準(zhǔn)品上新
- 【靶點(diǎn)模型】AKT基因的藥物開(kāi)發(fā)
- 研究揭示缺氧如何導(dǎo)致細(xì)菌引發(fā)痤瘡
- *針對(duì)肝癌的PD-1抗體獲FDA批準(zhǔn),國(guó)產(chǎn)PD-1抗體進(jìn)入三期
- 【藥靶模型】ESR1 Y537S模型開(kāi)發(fā)
- 免疫治療的下一個(gè)靶標(biāo):腫瘤相關(guān)巨噬細(xì)胞?
聯(lián)系我們
電話:4008750250
號(hào)碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號(hào)
Email: zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
基因檢測(cè)標(biāo)準(zhǔn)品 > 其他類別 > CBP80001-10bTMB-P1 (22.91) Reference Standard

- 詳細(xì)內(nèi)容
CBP80001-10 | |||||||||||||||||||||||||||||||||||||||||||||||
I. Background | |||||||||||||||||||||||||||||||||||||||||||||||
Tumor mutational burden (TMB) shows great promise as a biomarker for immuno-oncology (I-O) therapy response, but progress is hindered by the lack of a standardized TMB measurement by targeted NGS panels, and an absence of TMB reference materials.
| |||||||||||||||||||||||||||||||||||||||||||||||